Clearmind Medicine (CMND): Net earnings per share for the last 12 months

Clearmind Medicine Inc. (CMND) is navigating the complexities of psychedelic regulation and uncertainty regarding monetization timelines. The rolling annual earnings per share trend confirms current patterns, where -710.53 represents the latest level. The company is implementing energy saving and waste filtration in its laboratories, focusing on expanding its network of alcoholism clinics within a growing market.
Analytical breakdowns and data insights for company Clearmind Medicine (CMND)

The eps_ttm_co metric is calculated as the ratio of total annual net income to the number of shares outstanding. This metric measures the actual efficiency of business capitalization per share. For Clearmind Medicine Inc. (CMND), the value -710.53 reflects the financial result against the costs of diversifying research centers and psychedelic logistics. By analyzing changes in the rolling annual EPS, an investor assesses profit sustainability. Stagnation of this curve signals a risk of overpaying for the asset.